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INTRODUCTION
The use of conventional knockout (KO) technologies has provided 
valuable information in identifying the role of key genes in neu-
ral development and plasticity. While these methods have been of 
value, they are often accompanied by a number of limitations that 
can restrict their usefulness. For example, if a gene of interest is 
essential for development, then gene KO can lead to gross develop-
mental abnormalities or lethality that either preclude or complicate 
studies on adult animals (e.g., Asada et al., 1997). Developmental 
defects and compensatory changes caused by mutations often make 
it difﬁ  cult to assess whether phenotypic consequences result from 
the lack of normal gene expression in the adult animal or the lack 
of the normal expression during development. In addition, conven-
tional methods eliminate the gene of interest in peripheral tissues as 
well as the central nervous system, and thus are not limited to altera-
tions of brain molecular functions. Similarly, KO strategies produce 
broad changes in gene function throughout the neuroaxis and do 
little to identify the effects of such changes on speciﬁ  c brain regions 
or neural circuits thought to be involved in distinct functions. As a 
consequence, the complete deletion of a speciﬁ  c protein throughout 
the nervous system may prove ineffective toward understanding 
ﬁ  ne molecular processes in higher brain functions.
Cre/LoxP RECOMBINATION SYSTEM
To overcome these drawbacks, researchers are increasingly mak-
ing use of conditional gene manipulation strategies, which have 
the advantage of allowing temporal and spatial deletion of a gene 
of interest (Gaveriaux-Ruff and Kieffer, 2007). One such approach 
is the Cre/loxP recombination system. The Cre/LoxP technique 
was ﬁ  rst reported by Rajewsky and colleagues to KO the pol beta 
gene that encodes the DNA polymerase beta in T lymphocytes (Gu 
et al., 1994), but has since been utilized as a powerful and popular 
approach to understanding the genetic and molecular basis of higher 
brain functions and their role in animal behavior models. Generally, 
the system requires crossbreeding of two lines of mice. One line 
carries a transgene that encodes the Cre recombinase gene under the 
control of a cell-speciﬁ  c promoter. Cre recombinase is an enzyme 
that catalyzes the site-speciﬁ  c, irreversible cleavage of DNA segments 
ﬂ  anked by unique loxP sequences. The second line carries the tar-
get gene of interest bordered by the two requisite loxP recognition 
sites (Sauer and Henderson, 1988; Tsien et al., 1996). Each loxP site 
consists of two 13-bp palindromic sequences ﬂ  anking an 8-bp core 
sequence. They are typically located in intronic sequences bordering 
exon(s) of the target gene to preserve gene transcription prior to 
deletion. Mice homozygous for this conditional ‘floxed’ (f lanked 
by loxP) allele display a wild-type phenotype in the absence of Cre 
recombinase. However, crossbreeding with a Cre-expressing mouse 
line produces a null allele after Cre-mediated recombination.
In the Cre recombinase mouse, the spatio-temporal pattern of 
Cre activity can be assessed in vivo by using traditional immu-
nohistochemistry or in situ hybridization for Cre recombinase or 
using sensitive Cre reporter mouse lines. Many reporter strains use 
different promoters to express lacZ, green ﬂ  uorescent protein (GFP) 
or other detectible proteins in the presence of Cre recombinase 
(van der Neut, 1997; Lobe et al., 1999; Mao et al., 2001; Srinivas 
et al., 2001; Morozov et al., 2003; Morozov, 2008). It is important 
to note that there is great variability between the sensitivity of 
these reporter lines. If the reporter protein is not expressed in a 
particular cell-type, it does not prove that Cre is not expressed or 
that it would not be active on a different gene locus. Despite these 
limitations, this approach has proved quite successful in a large 
number of studies to date.
The use of lentiviral vectors and Cre/loxP to investigate 
the function of genes in complex behaviors
Scott A. Heldt and Kerry J. Ressler*
Howard Hughes Medical Institute, Department of Psychiatry and Behavioral Sciences, Yerkes National Primate Research Center, Emory University, Atlanta, GA, USA
The use of conventional knockout technologies has proved valuable for understanding the role 
of key genes and proteins in development, disease states, and complex behaviors. However, 
these strategies are limited in that they produce broad changes in gene function throughout the 
neuroaxis and do little to identify the effects of such changes on neural circuits thought to be 
involved in distinct functions. Because the molecular functions of genes often depend on the 
speciﬁ  c neuronal circuit in which they are expressed, restricting gene manipulation to speciﬁ  c 
brain regions and times may be more useful for understanding gene functions. Conditional 
gene manipulation strategies offer a powerful alternative. In this report we brieﬂ  y describe two 
conditional gene strategies that are increasingly being used to investigate the role of genes 
in behavior – the Cre/loxP recombination system and lentiviral vectors. Next, we summarize a 
number of recent experiments which have used these techniques to investigate behavior after 
spatial and/or temporal and gene manipulation. These conditional gene targeting strategies 
provide useful tools to study the endogenous mechanisms underlying complex behaviors and 
to model disease states resulting from aberrant gene expression.
Keywords: lentivirus, gene therapy, fear, PTSD, amygdala, hippocampus, inducible knockout
Edited by:
William Wisden, Imperial College, UK
Reviewed by:
Peer Wulff, University of Aberdeen, UK
Alastair M. Hosie, 
Imperial College London, UK
*Correspondence:
Kerry J. Ressler, Howard Hughes 
Medical Institute, Department of 
Psychiatry and Behavioral Sciences, 
Center for Behavioral Neuroscience, 
Yerkes Research Center, Emory 
University, 954 Gatewood Dr, Atlanta, 
GA 30329, USA. 
e-mail: kressle@emory.eduFrontiers in Molecular Neuroscience  www.frontiersin.org  November 2009  | Volume 2  |  Article 22  |  2
Heldt and Ressler  Lentivirus-Cre/loxP for manipulation of behavior
One commonly used reporter is the ﬂ  oxed-stop lacZ reporter 
mice (Soriano, 1999).These mice possess a transgene integrated 
into the ROSA26 locus which consists of a ﬂ  oxed-stop sequence 
upstream of a lacZ gene (Gardner et al., 1996; Takahashi et al., 
2000). When these RosaLacZ mice are crossed with Cre-express-
ing transgenic mice, the Cre-mediated excision of the ﬂ  oxed-stop 
sequence leads to lacZ expression. The expression of LacZ in these 
animals serves as an extremely sensitive measure, with very low 
background expression levels. In these animals, Cre expression 
can be detected by beta galactosidase (β-gal) immunohistochem-
istry, utilization of the β-gal colorimetric substrate X-gal, or by 
in situ hybridization.
GENE MANIPULATION USING MICE WITH FLOXED GENES OF 
INTEREST CROSSED WITH Cre-EXPRESSING LINES
In recent years numerous mouse lines that carry a Cre recombi-
nase transgene have been engineered (see, Morozov et al., 2003). 
Cre-expressing lines can be made both with traditional transgene 
technology as well as with knock-in lines that use the homologous 
recombination technique. In this case a Cre cassette is placed down-
stream of the endogenous gene promoter at the speciﬁ  c locus of that 
gene. In mice engineered using such an approach, the expression 
of Cre is consistent with what is known about the spatio-temporal 
expression pattern of the endogenous gene (e.g., Zhuang et al., 
2005). A number of studies investigating learning and memory 
in mice have utilized the Emx1-Cre and the CaMKII-Cre trans-
genic knock-in lines (Guo et al., 2000; Casanova et al., 2001). Both 
Emx1 and CaMKII-promoter driven Cre expression cause effective 
deletion in the cerebral cortex, hippocampus and other forebrain 
regions. When these transgenic Cre-expressing mice are crossed 
with Cre-sensitive reporter lines, such as the Rosa26 line contain-
ing lacZ ﬂ  anked by LoxP, the high-efﬁ  ciency and speciﬁ  city of the 
expression pattern is observed. When these Cre-expressing mice 
are crossed with such ‘ﬂ  oxed’ mice, the targeted gene is effectively 
deleted throughout the cerebral cortex, hippocampus and other 
forebrain regions that are speciﬁ  c to the promoter driving Cre. 
Although there are many advantages to these knock-in approaches, 
there are also several drawbacks. One limitation is the risk of haplo-
insufﬁ  ciency when Cre recombinase replaces the gene of interest, 
thus leading to mice that express only a single allele of the targeted 
gene. One way of solving this issue has been to utilize the ‘inter-
nal ribosomal entry site’ (IRES) sequence, which was originally 
described from the picornavirus (Zhu et al., 2001). This sequence, 
when placed between two coding sequences of DNA allows for co-
expression of both genes off of a single transcribed mRNA. Thus, 
a knock-in may place an IRES-Cre or other expression marker 
downstream of the gene of interest, which in some cases solves the 
issue of haplo-insufﬁ  ciency allowing equivalent expression of both 
genes from the single endogenous promoter.
Alternatively, a line can be engineered by pronuclear injection 
of a fusion construct in which the Cre coding sequence is inserted 
downstream of a cell-speciﬁ  c promoter. In this approach, the trans-
gene will be integrated into the genome randomly, thus the pattern 
of Cre expression, with some insertion events, may be somewhat 
different from that of the promoter’s endogenous gene pattern. Of 
note, these transgenic approaches can result in more than one inser-
tion event as well as position effects on gene expression speciﬁ  city 
and efﬁ  ciency. Homologous recombination, ‘Knock-in’ strategies 
are signiﬁ  cantly more effortful to produce, but are generally more 
assured of the expected expression pattern.
With Cre transgenic lines, as with Cre knock-in lines, genetic 
excision occurs as soon as the promoter driving Cre expression is 
active and may trigger developmental compensations if the pro-
moter is active during embryogenesis. As an example, Chhatwal 
et al. (2007) recently engineered a Cre-expressing line by subclon-
ing the Cre coding sequence downstream of a promoter of the 
gene for cholecystokinin (CCK). The resulting plasmid (CCID) was 
linearized, puriﬁ  ed and microinjected into the pronuclei of one-
cell embryos, which were then implanted into pseudo-pregnant 
females to create a number of transgenic CCK-Cre driver mouse 
lines. When these animals were mated to Rosa-LacZ reporter mice, 
animals carrying both the CCID and Rosa-LacZ transgenes show 
varying expression patterns of β-gal in areas where endogenous 
CCK is expressed Figure 1. Similarly, when the neocortex-speciﬁ  c 
CCID transgenic line was crossed with a ﬂ  oxed-stop GFP reporter 
line (Mao et al., 2001; Muzumdar et al., 2007), animals carrying 
both transgenes show GFP expression (limited to the neocortex 
with no expression in other areas like the hippocampus, thalamus, 
striatum, hypothalamus or amygdala; Figure 1).
LENTIVIRAL VECTORS AS TOOLS TO RESTRICT TRANSGENE 
EXPRESSION
Because the molecular functions of proteins often depend on the 
speciﬁ  c neuronal circuit in which they are expressed, restricting 
gene manipulation to speciﬁ  c regions and time may be a more 
useful in understanding the function of genes in some complex 
behaviors. In such cases, the use of lentiviral vectors to deliver trans-
genes is a powerful tool. Lentivirus vectors integrate into both divid-
ing and post-mitotic cells, generate little or no immune response, 
and express transgenes stably over several months (Naldini et al., 
1996; Lai and Brady, 2002). Currently used HIV-derived lentivi-
ruses contain only the necessary elements for gene transduction 
and include self-inactivating elements, which signiﬁ  cantly improve 
the biosafety of vectors and greatly reduces the formation of rep-
lication competent viruses (Zufferey et al., 1998; Abordo-Adesida 
et al., 2005). Furthermore, in comparison to adeno-associated- and 
sindbis-based vectors, lentiviral vectors have a larger insert capacity. 
Thus, large transgenes can be subcloned into lentivirus vectors ena-
bling the expression of genes encoding neurotransmitters (Azzouz 
et al., 2002), neuropeptides (Keen-Rhinehart et al., 2009), mutated 
receptors (Rattiner et al., 2004a; Chhatwal et al., 2006), small inter-
fering RNAs (Tiscornia et al., 2003), and promoters for the use of 
transgene expression in selected populations of cells (Chhatwal 
et al., 2007). Lastly, lentiviral vectors, as compared to transgenic and 
knock-in mouse approaches, provide researchers with the choice of 
using rats or a variety of mouse strains at different ages. Note that 
age of the animal at the time of gene deletion may be particularly 
important in particular experimental designs or models.
For many of these reasons, the use of lentiviral vectors to deliver 
Cre recombinase is a useful alternative to the use of transgenic 
Cre-expressing mouse lines. Cre-expressing lentiviruses can be 
injected in a localized fashion directly into the brain of ﬂ  oxed 
mice, and the extent of the conditional genetic deletion will be 
restricted to the area of viral spread. For example, viral vectors Frontiers in Molecular Neuroscience  www.frontiersin.org  November 2009  | Volume 2  |  Article 22  |  3
Heldt and Ressler  Lentivirus-Cre/loxP for manipulation of behavior
ADENO-ASSOCIATED VIRAL VECTORS
Although this review is devoted to lentiviral vector approaches, we 
will say a few words about adeno-associated vectors and some of 
the reasons why one might choose one over the other system for 
genetic manipulation. Generally, the lentiviral vector system utilizes 
a signiﬁ  cantly larger insert size, and is thus the optimal choice when 
larger gene inserts, more than one gene (poly-cistronic cassettes), 
and longer promoters are of primary importance. Additionally, 
lentiviruses are somewhat easier to concentrate and there is some 
evidence that they express for the lifetime of the cell/animal. In 
contrast AAV are easier to handle (do not require same level of 
BSL safety due to their not being a retrovirus-based backbone), 
and in some cases higher titers are possible with AAV. Several 
manuscripts have been published recently outlining important 
differences between AAV and lentiviral vectors for neuroscience 
applications (Nathanson et al., 2009; Towne and Aebischer, 2009; 
van den Pol et al., 2009).
used in a number of labs are derived from the lentivirus backbone 
pLV-CMV-GFP-U3Nhe (Naldini et al., 1996; Tiscornia et al., 2003; 
Jasnow et al., 2009), which allows for virally mediated expression 
of GFP (LV-GFP) driven by a cytomegalovirus (CMV) promoter. 
For manipulation of gene expression using ﬂ  oxed mice, a Cre-
recombinase expressing viral vector (LV-Cre) can be created by 
replacing the GFP coding sequence with the coding sequence for 
Cre-recombinase (Heldt et al., 2007). In a typical experiment, mice 
are injected intra-cranially into speciﬁ  c brain areas with 1–2 µl of 
virus bilaterally, and allowed to recover for 7–14 days for stable 
integration and expression of the transgene within the host genome. 
Figure 2 shows the ability of LV-Cre to efﬁ  ciently remove the ﬂ  oxed-
stop sequences upstream of lacZ in the Rosa-LacZ reporter mice 
(129S-Gt(ROSA)26Sortm1Sor/J, Soriano, 1999). LV-Cre injected 
into the striatum (Figures 2A,B) or CA1/dentate gyrus (DG) region 
of the dorsal hippocampus (Figures 2C–E) induces strong produc-
tion of LacZ with no leakage in areas not infected with virus.
A C
E D
B
FIGURE 1 | Cre recombinase expressing transgenic mice. A DNA template in 
which the coding sequence for Cre recombinase was placed under the control of 
the CCK promoter (CCID) was used to create transgenic mouse lines. Three 
founder animals, with distinct transgene insertion sites, were generated and bred 
to RosaLacZ animals to assess Cre expression as revealed by LacZ staining. 
(A) Normal patterns of CCK mRNA expression, revealed with in situ hybridization 
for CCK mRNA. (B) Animals from transgene line A show low levels of Cre 
expression, but in appropriate CCK-speciﬁ  c regions. (C) Animals from line B 
relatively widespread expression, which was, with the exception of the dentate, 
similar to endogenous CCK mRNA expression. (D) Animals from line C showed 
high levels of Cre expression in the cortex, in a manner that was qualitatively 
similar to observed patterns of CCK mRNA expression but with virtually no Cre 
expression in hippocampus or subcortical regions. (E) Animals from transgenic 
line C were crossed with Td tomato/ﬂ  oxed stop GFP , to assess Cre mediated GFP 
expression. These mice express strong red ﬂ  uorescence in all tissues and cell 
types examined. When bred to Cre recombinase expressing mice, the resulting 
offspring have the stop cassette deleted in the Cre expressing tissue, deleting Td 
tomato expression and allowing expression of the membrane-targeted GFP 
(red = Td tomato, green = eGFP , blue = DAPI; Left – GFP expression, Right – 
merged GFP + TdTomato expression). Panels (A–D) from Chhatwal et al. (2007).Frontiers in Molecular Neuroscience  www.frontiersin.org  November 2009  | Volume 2  |  Article 22  |  4
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THE USE OF LENTIVIRUSES IN DEMONSTRATING THE ROLE OF 
BDNF-TrkB SYSTEM IN LEARNING AND MEMORY
Here we will illustrate several different in vivo uses of these vec-
tors in approaching neuroscience questions. Lentiviruses have been 
particularly useful in demonstrating the role brain-derived neuro-
trophic factor (BDNF) and its receptor tyrosine kinase B (TrkB) 
in learning and memory, including the acquisition and extinction 
of conditioned fear. Although its functions in the adult brain are 
not entirely clear, BDNF undoubtedly plays a role in development, 
trophic support, neural plasticity, and neuroprotection after some 
brain insults (Lindvall et al., 1994). There is increasing evidence that 
BDNF exerts acute effects on synaptic transmission and partici-
pates in long-term potentiation (LTP), an event related to memory 
processes (Patterson et al., 1992; Korte et al., 1995; Thoenen, 1995; 
McAllister, 1999).
However, understanding the role of the central BDNF-TrkB 
system in vivo within behaviorally relevant learning paradigms 
has been difﬁ  cult (Minichiello et al., 2002). In part, this difﬁ  culty 
is due to the lack of speciﬁ  c pharmacological antagonists for the 
Many of the approaches discussed above have also been nicely 
demonstrated with AAV, along with several recent exciting inno-
vations. For example novel combinations of Cre recombinase and 
channel rhodopsin (see below) have been used with AAV vectors 
to ‘tag’ neuronal populations for identiﬁ  cation during in vivo elec-
trophysiological recording (Lima et al., 2009). Another novel use 
of Cre in an AAV system used a modiﬁ  ed estrogen-inducible Cre 
recombinase that served as an in vivo ‘molecular switch’, allow-
ing spatial and temporal control of transgene expression, thereby 
potentially increasing the safety of gene therapy (Li et al., 2006). 
Additionally, the use of Cre-activated transgenes with AAV provide 
an additional assortment of possibilities for gene manipulation. 
For example, the ‘rAAV-FLEX-rev’ delivery approach has been 
demonstrated to lead to the expression of transgenes in a tem-
porally and spatially restricted manner, using any Cre driver line 
as the template. (Atasoy et al., 2008). Overall, as with lentiviruses, 
AAV vectors allow for rapid subcloning and engineering of novel 
approaches to manipulate gene expression within discrete brain 
regions and neuronal cell types.
A Control LV-Cre B
CD
E
FIGURE 2 | In vivo validation of LV-Cre lentivirus. Robust Cre 
recombinase expression as labeled by LacZ when LV-Cre is injected into 
RosaLacZ reporter mice. Sections were processed for lacZ histochemistry 
with β-gal 14 days after LV-Cre injections to visualize Cre-dependent 
recombination in vivo in the (A,B) striatum and (C,E) dorsal hippocampus 
seen at ×10 and ×20 magniﬁ  cation. LV-Cre-infected cells within (D) CA1 
and (E) DG, illustrating the dense β-gal and intact morphology of 
hippocampal neurons.Frontiers in Molecular Neuroscience  www.frontiersin.org  November 2009  | Volume 2  |  Article 22  |  5
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TrkB receptor. In addition, homozygous BDNF KO mice display 
profound developmental abnormalities and often die prior to their 
third postnatal week (Ernfors et al., 1994). Heterozygous BDNF 
KO mice are viable but develop with roughly half of wild-type 
BDNF levels throughout the brain which likely leads to altera-
tions in development that alter normal functioning (Conover and 
Yancopoulos, 1997). Given their time- and spatially limited gene 
expression characteristics, lentiviruses can be used to manipulate 
the BDNF-TrkB system after normal development, and thus, pro-
vide a more accurate assessment for the role of BDNF plasticity in 
learning and memory.
HIPPOCAMPUS-SPECIFIC DELETION OF BDNF IMPAIRS 
SPATIAL MEMORY AND EXTINCTION OF AVERSIVE 
MEMORIES
The mammalian hippocampus is the brain region containing the 
highest BDNF mRNA and protein levels (Conner et al., 1997). 
BDNF is known to have a functional role in the neuronal plastic-
ity associated with hippocampal LTP (Korte et al., 1995). Although 
hippocampal circuits are quite plastic and clearly involved in learn-
ing and memory, the contribution of these circuits to the behaviors 
under study is often unclear. Correlational studies show that BDNF 
is increased in its expression following hippocampal dependent 
tasks (Hall et al., 2000; Mizuno et al., 2000). Genetic manipula-
tion studies suggest that animals with decreased levels of BDNF 
or its receptor, TrkB, are deﬁ  cient in behavioral tasks thought to 
be hippocampally dependent (Linnarsson et al., 1997; Minichiello 
et al., 1999; Gorski et al., 2003; Monteggia et al., 2004; Duman and 
Monteggia, 2006). However, all of these studies are limited, in that 
none of them examined the effects of BDNF deletion only within 
the hippocampus of adults while sparing BDNF in other forebrain 
regions. Having deletions of BDNF limited to only the hippocam-
pus and only during a time-limited period in adulthood may also 
lead to a number of differences compared with the developmental 
and spatially broader BDNF deletions studied earlier.
To address this issue, we examined the consequence of hippoc-
ampus-speciﬁ  c BDNF deletion in adult animals on the acquisi-
tion and extinction of fear, object recognition memory, and a task 
strongly dependent on hippocampal functioning – the Morris water 
maze (MWM, Morris et al., 1982). Hippocampal BDNF was deleted 
by performing bilateral injections of LV-Cre into the dorsal hippoc-
ampus of BDNF-ﬂ  oxed mice (Heldt et al., 2007). Initial veriﬁ  cation 
of this approach was performed with unilateral injections followed 
14 days later with in situ hybridization for the Cre-recombinase or 
BDNF mRNA. Figure 3A reveals BDNF mRNA expression, which 
was speciﬁ  cally deleted within the hippocampus where Cre recom-
binase was now expressed.
In animals used for behavioral tests, both qualitative and 
quantitative analyses of mRNA expression levels reveal that the 
bilateral deletion of BDNF in the mice was largely limited to the 
hippocampus. Figure 3B shows the qualitative decrease in BDNF 
expression within the dorsal hippocampus following LV-Cre infec-
tion. Quantitative analyses of levels of BDNF revealed that, with 
reference to GFP control animals, the relative expression level 
of remaining BDNF within the dorsal hippocampus of LV-Cre-
infected animals was 35, 30 and 45% for DG, CA1 and CA3, respec-
tively (Figure 3C).
In the MWM, BDNF deletion within dorsal hippocampus 
caused deﬁ  cits in escape latencies during acquisition as well as 
during probe trials when compared to the performance of control 
animals. BDNF hippocampal deletions also reduced the amount of 
time spent with the novel compared to the habituated object in the 
novel object recognition task (Figures 3D,E). Past studies indicate 
heterozygous and forebrain-speciﬁ  c BDNF KO mice likewise have 
deﬁ  cits in MWM learning and other hippocampal dependent tasks 
(Mizuno et al., 2000; Gorski et al., 2003). However, these KO lines 
lack BDNF during development throughout cortical and subcorti-
cal areas as well as hippocampus. Together these data support the 
concept that BDNF expression in adults is required for normal 
acquisition and expression of spatial learning tasks, and that these 
previously reported effects were not due to developmental altera-
tions or long-term BDNF effects on hippocampal neuronal survival 
or morphology.
Interestingly, hippocampal BDNF deletion also disrupted the 
extinction of conditioned fear without effecting the initial acquisi-
tion of fear. LV-Cre and LV-GFP mice given tone CS + footshocks 
during Pavlovian fear training showed equivalent levels of condi-
tioned fear during testing. However, when groups were subsequently 
tested for fear over the course of next 6 days, LV-Cre mice displayed 
less fear extinction than controls, suggesting that hippocampal 
BDNF is required for the neural plasticity underlying the acquisi-
tion or consolidation of extinction memories (Figure 4). Impaired 
extinction resulting from decreased hippocampal BDNF offers new 
avenues for understanding emotion regulation in patients with 
anxiety disorders.
BDNF AND TrkB RECEPTOR INVOLVEMENT IN AMYGDALA-
DEPENDENT FEAR CONDITIONING AND EXTINCTION
In addition to the hippocampus and mPFC, it is well established 
that fear conditioning is dependent on the basolateral amygdala 
(BLA) (Davis et al., 1993; Fanselow and LeDoux, 1999). Previous 
ﬁ  ndings using in situ hybridization have revealed temporally spe-
ciﬁ  c increases in BDNF mRNA in the BLA after associative fear con-
ditioning but not after exposure to an equal number of CS-alone or 
US alone presentations (Ressler et al., 2002; Rattiner et al., 2004a,b). 
Fear conditioning also results in activation of the TrkB receptor in 
the amygdala, as indicated by increased receptor phosphorylation 
during consolidation period (Rattiner et al., 2004a). In addition 
to the increased production of amygdala BDNF mRNA during the 
consolidation of fear conditioning, levels of BDNF mRNA tran-
scripts are also increased following the extinction of conditioned 
fear (Chhatwal et al., 2006).
TrkB is a classical receptor tyrosine kinase, which is activated by 
BDNF binding, leading to receptor homodimerization, transphos-
phorylation and subsequent activation for downstream signaling 
required for neuroplasticity processes. The homodimerization 
of TrkB makes them particularly amenable to study with domi-
nant-negative truncated recombinant proteins (Klein et al., 1991). 
Truncated TrkB receptors have extracellular domains which are 
identical to the full-length receptors, allowing for ligand binding, 
but also contain a shortened intracellular domain that inhibits 
BDNF signaling by blocking Trk autophosphorylation (Saarelainen 
et al., 2000; Haapasalo et al., 2001). Truncated TrkB receptor genes 
can be delivered in a spatial, temporal, and discrete manner using Frontiers in Molecular Neuroscience  www.frontiersin.org  November 2009  | Volume 2  |  Article 22  |  6
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lentiviral vectors, and in turn, these vectors can be used to evaluate 
the role of central BDNF-TrkB mechanisms in behaviorally relevant 
learning paradigms.
The use of a viral gene-delivery system to express a dominant-
negative truncated TrkB receptor (TrkB.t1) has been successfully 
employed to examine the role of BLA TrkB receptors in the acquisi-
tion and consolidation of conditioned fear and fear extinction, as 
assessed by fear-potentiated startle (FPS, Chhatwal et al., 2006). For 
the acquisition of fear, this involved giving rats bilateral infusions 
of a lentivirus expressing TrkB.t1 (LV-TrkB.T1) or LV-GFP into 
the BLA 2 weeks before training and testing. To examine whether 
acquisition deﬁ  cits were due to impaired expression, a second group 
of animals received BLA infusions of LV-TrkB.t1 or LV-GFP 4 days 
after training (Rattiner et al., 2004a). This ability to manipulate 
gene expression before vs. after the learning paradigm illustrates 
one of the strengths of viral vector approaches.
To conﬁ rm the applicability of these vectors in vivo, animals 
injected with LV-TrkB.t1 or LV-GFP were sacriﬁ  ced after behavio-
ral procedures. In LV-GFP infected rats, a large number of GFP-
 positive cells were identiﬁ  ed in the amygdala, whereas rats infected 
with LV-TrkB.t1 showed a large number of TrkB.t1-positive cells 
in the amygdala, indicating that cells in the amygdala were suc-
cessfully infected with these lentiviruses (Figures 5A–C). As seen 
in Figure 5D, pretraining infusion of LV-TrkB.t1 caused impaired 
fear learning when animals were tested 48 h after the last training 
session. In contrast, post-training infusion of LV-TrkB.t1 produced 
no signiﬁ  cant deﬁ  cits (Figure 5E), indicating that genetic blockade 
of the TrkB receptors did not prevent the expression of fear.
To examine the role of amygdala TrkB mechanisms in the for-
mation of extinction memories, rats were fear-conditioned and 
matched into two groups with equivalent levels of conditioned fear 
before virus infusion of LV-GFP or LV-TrkB.t1 into the BLA bilater-
ally. When tested 2 days after extinction training, rats infected with 
the TrkB.t1 dominant-negative virus expressed more fear than those 
with the GFP virus, suggesting that blockade of the TrkB receptors 
prevented the retention of extinction memories (Figure 5F).
A separate cohort of animals was used to determine whether the 
extinction deﬁ  cit in LV-TrkB.t1 rats was a result of the deﬁ  ciencies in 
initial encoding or the consolidation of extinction memories. After 
fear-conditioned, matching and viral surgery, rats were tested for fear 
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FIGURE 3 | Inducible BDNF deletion in hippocampus with Cre lentivirus. 
(A) BDNF (top) and Cre-recombinase (middle) mRNA expression visualized with 
in situ hybridization 2 weeks after LV-Cre infection into BDNF-ﬂ  oxed mice. The 
bottom ﬁ  gure represents a pseudocolor overlay of the two in situ sections, 
demonstrating that Cre, but not BDNF , is now expressed where BDNF was 
previously expressed. (B) Qualitative ﬁ  gure showing BDNF in situ hybridization 
of dorsal hippocampus following a sham injection (top, −Cre) or following LV-Cre 
injection (bottom, +Cre). (C) Relative mRNA expression in dentate gyrus (DG), 
and CA1 and CA3 regions and the average of all regions (Avg) of dorsal 
hippocampus in LV-Cre (Cre)- or LV-GFP (GFP)-infected mice. (D) Morris water 
maze acquisition, measured as the average latency to ﬁ  nd the platform over 
daily sessions of training. LV-Cre-infected mice demonstrated signiﬁ  cantly 
slower acquisition (impairment) compared with LV-GFP-infected controls. (E) 
Percent of time spent exploring the new vs. old object during the test day for 
novel object recognition. LV-GFP-infected mice spent signiﬁ  cantly more time 
exploring the novel compared to the previously habituated object. The 
LV-Cre-infected animals did not differentiate between the two, demonstrating 
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potentiated startle over multiple days to measure both within- and 
between session extinction of fear (Figure 5G). Testing revealed no 
difference between the groups in the rate of within-session extinction 
as observed by the decreased levels of FPS across test trials. However, 
rats expressing TrkB.t1 demonstrated signiﬁ  cantly less extinction 
across several days of extinction testing, as compared to LV-GFP rats 
which showed marked extinction across days. This suggests that these 
rats may initially encode the extinction memory within each session 
but are not able to consolidate it. Together, these data suggest that 
the TrkB receptor is not involved in the process of within-session 
encoding of fear extinction, but instead is required for the normal 
consolidation of extinction as measured during the retention test.
EXPRESSION OF CORTICOTROPIN-RELEASING FACTOR IN THE 
AMYGDALA EMULATES STRESS DYSREGULATION
In addition to using lentiviral vectors to KO the gene or inhibit 
the protein of interest, lentiviruses can also over-express a speciﬁ  c 
protein as a means of elucidating protein function. Constitutive 
gene expression may be particular useful to model disease states 
resulting from an overactive gene or as a means of gene replace-
ment for recovery of function experiments. An example of this 
application is contained in a recent study which sought to over-
express corticotropin-releasing factor (CRF) in an effort to model 
physiological and behavioral changes observed in stress-related 
pathologies (Keen-Rhinehart et al., 2009). Past research suggests 
that CRF is upregulated in central nucleus of the amygdala (CeA) 
during chronic stress (Makino et al., 1999) and is related with the 
upregulation of adrenocorticotropic hormone release from the 
pituitary which is crucial for the adaptation to prolonged exposure 
to stressors (Herman et al., 2003). A dysregulation of this control 
may be involved in the development of a maladaptive response to 
chronic stress and may produce many of the alterations observed 
in several stress-induced pathologies including PTSD, anxiety, and 
depression (Arborelius et al., 1999; Swaab et al., 2005). Transgenic 
mice that over-express CRF indeed exhibit HPA dysregulation 
(Groenink et al., 2002). However, this approach likely produces 
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FIGURE 4 | Impaired fear extinction in mice with hippocampus-speciﬁ  c 
BDNF deletions. (A) Acquisition of cue conditioned fear, as measured with 
freezing after the onset of the auditory CS, during the conditioned fear 
acquisition session. There was no difference in acquisition of fear in animals 
receiving bilateral hippocampal injections of LV-Cre or LV-GFP . (B) Animals were 
tested within the same context in which training occurred for the presence of 
contextual fear as measured with freezing. There was no difference between the 
groups on level of contextual fear. (C,D) Extinction of conditioned fear is 
impaired in mice with dorsal hippocampus BDNF deletions. (C) Percent FPS is 
graphed for the ﬁ  rst post-fear training test (pre-extinction) vs. the last test (post-
extinction). Mice infected with LV-GFP demonstrate signiﬁ  cant decreases in 
their level of conditioned fear as measured with %FPS compared with 
LV-Cre-infected mice. (D) Impaired extinction of fear, measured with %FPS, is 
stable across multiple testing sessions. Panels adapted from Heldt et al. (2007).Frontiers in Molecular Neuroscience  www.frontiersin.org  November 2009  | Volume 2  |  Article 22  |  8
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developmental compensation within the system that does not 
likely mimic the consequences of region-speciﬁ  c increased CRF 
expression resulting from chronic stress. Using lentiviral vectors, 
Keen-Rhinehart et al. (2009) recently examined whether constitu-
tive expression of CRF in the CeA of rats produced changes in the 
regulation of the HPA axis and behaviors shown previously to be 
indicative of chronic stress.
In this study, a lentivirus construct was engineered to over-
express CRF by subcloning the CRF cDNA sequence downstream 
of the constitutively active CMV promoter. After injections of either 
the LV-CRF or LV-GFP control virus, female rats were administered 
a battery of tests, including the Porsolt forced swim test and the 
acoustic startle response which is elevated in fear and anxiety states 
(Davis et al., 1993). The dexamethasone (DEX) suppression test 
was conducted to assess the consequences of increased CRF release 
from CeA on glucocorticoid negative feedback.
Histological analysis after testing indicated that the CRF pro-
tein concentration was signiﬁ  cantly elevated in the CeA of rats 
that received LV-CRF when compared with LV-GFP animals, indi-
cating that the LV-CRF site-speciﬁ  cally increased synthesis of CRF 
in CeA (Figure 6). Prior testing revealed that LV-CRF animals 
showed a number of physiologic and behavioral signs typically 
exhibited by animals subjected to chronic stress (Figure 7). In the 
DEX suppression test, plasma corticosterone levels were signiﬁ  -
cantly elevated in LV-CRF animals compared to controls by 6 h 
post injection, indicating that the LV-CRF animals had escaped 
from glucocorticoid negative feedback. As revealed in behavio-
ral tests, the baseline acoustic startle response was signiﬁ  cantly 
greater in LV-CRF compared with LV-GFP-injected rats, suggest-
ing that basal levels of anxiety are increased in the LV-CMV-CRF 
group. In the Porsolt forced swim test, LV-CRF animals displayed 
less time attempting to escape and more immobile ﬂ  oating time 
than controls, behaviors indicative of an increased depression-
like state in rats.
Together, the data from this study demonstrate that lentiviral 
over-expression of CRF in CeA of rats induces phenotypic behav-
iors reminiscent of traits associated with a state of chronic stress. 
Moreover, it revealed the value of using lentiviral vectors to con-
stitutively express genes to model disease states resulting from an 
overactive gene.
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FIGURE 5 | Effect of TrkB.T1 in the amygdala on the acquisition of 
conditioned fear and extinction. (A–C) Histological examination of viral 
infection in the BLA following behavioral studies. (A) No amygdala damage was 
seen following infection as visualized with Cresyl violet staining. LA, lateral 
amygdala; CeA, central amygdala. (B) Expression of TrkB.t1 was assessed using 
immunocytochemistry (ICC) for a hemagglutinin (HA) epitope tag incorporated 
into the TrkB.t1 coding sequence. (C) GFP expression directly visualizing under 
an epiﬂ  uorescence microscope (scale bar, 1 mm). Level of fear-potentiated 
startle (FPS) following (D,E) acquisition and (F,G) extinction of fear. (D) Mean 
startle amplitude on startle-alone trials, light-startle trials, and the difference 
between the two are shown for animals receiving lentivirus infusion into the 
amygdala. Mean difference scores of LV-TrkB.T1-infused animals were 
signiﬁ  cantly lower than difference scores of LV-GFP-infused animals. (E) Effect 
of amygdala infection with LV-TrkB.T1 on the expression of fear-potentiated 
startle. When LV-TrkB.T1 is present during expression, but not acquisition, of fear 
learning there is no difference between FPS with LV-TrkB.T1 animals compared 
with LV-GFP animals. (F) Averaging across all trials, TrkB.t1-infected rats showed 
a deﬁ  cit in extinction as compared to GFP-infected rats. (G) Examining extinction 
within the testing session suggested that the TrkB.t1-infected rats had normal 
within-session extinction, but lacked extinction retention across the 2-day 
interval between tests TrkB.t1 and GFP groups. Panels (A–C, F,G) adapted from 
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Promoters are generally deﬁ  ned as regions a few hundred to 
thousand base pairs located upstream of a gene’s transcriptional ini-
tiation site; however, more distal regions and 5′ and 3′ untranslated 
regions (UTR), may also contain various regulatory elements that 
govern transcription and cell-type speciﬁ  city. As such, transgenes 
containing full-length promoter/enhancer regions often exceed the 
limited insert capacity of lentiviral vectors. Thus, for lentivirus-
based applications, it is essential to identify a minimal promoter 
region that is important for cell-type speciﬁ  city which efﬁ  ciently 
drives gene expression and is also small enough to be packaged 
efﬁ  ciently as a viral vector.
The process of determining minimal promoter lengths usually 
involves the screening of several short versions of putative pro-
moter/enhancer regions by cloning the core or minimal proximal 
USES OF LENTIVIRAL VECTORS TO CREATE REGION AND CELL 
TYPE-SPECIFIC TRANSGENE EXPRESSION
An essential characteristic of most viral vectors is that they do not 
require a region-speciﬁ  c promoter. At present many lentiviruses 
use the constitutive CMV promoter which drives the ubiquitous 
expression of a downstream transgene not conﬁ  ned to just one 
subtype of cells. Thus, it is difﬁ  cult to attribute whether phenotypic 
alterations caused by transgene transcription are the consequence 
of intended targeted manipulation in desired cells or unintended 
effects on non-target cells. This complexity highlights the value 
of restricting transgene expression within speciﬁ  c types of cells. 
For this reason, restricting expression to speciﬁ  c cell populations 
through the use of a cell type-speciﬁ  c promoter is particularly 
attractive in future research.
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FIGURE 6 | LV-CRF injection into the central nucleus of the amygdala 
(CeA) signiﬁ  cantly increased corticotrophin releasing hormone (CRF) 
protein production site-speciﬁ  cally. (A) Number of positively labeled CRF 
cells in CeA of LV-GFP (closed bars) and LV-CRF treated rats (open bars) 
determined by immunohistochemistry. (B) Cresyl violet stained section 
representing a section parallel to the sections used to quantify the number of 
CRF positive neurons in CeA. (C) Representative section with an additional 
×20 magniﬁ  cation inset showing the effects of LV-CRF injection into CeA on 
the number of positively labeled CRF neurons. (D) Representative section 
with an additional ×20 magniﬁ  cation inset showing the amount of CRF 
staining observed in the control, LV-GFP-treated rats. *P < 0.05. Panels 
adapted from Keen-Rhinehart et al. (2009).Frontiers in Molecular Neuroscience  www.frontiersin.org  November 2009  | Volume 2  |  Article 22  |  10
Heldt and Ressler  Lentivirus-Cre/loxP for manipulation of behavior
regions of a promoter and assessing their activity and appropriate 
expression speciﬁ  city in vitro and in vivo. An example of the in vivo 
screening process has been reported by Chhatwal et al. (2007) who 
recently engineered a minimal promoter of the gene for CCK, an 
abundant neuropeptide of signiﬁ  cant interest in psychiatry and 
neuroscience (Fink et al., 1998). In this study, lentivirus constructs 
were engineered to express either a Cre recombinase or GFP under 
control of an upstream a 3-kb promoter region of the CCK gene that 
included 5′ UTR sequences. The resulting CCK-Cre and CCK-GFP 
lentiviral constructs were assessed in vivo by comparing the expres-
sion pattern of constructs to endogenous CCK mRNA expression 
after microinjection of packaged lentivirus.
Both CCK-Cre and -GFP viruses (LV-CCK-Cre, LV-CCK-GFP) 
were injected into the CA1 and DG regions of the hippocampus 
which possess a large number of CCK mRNA-positive cells located 
close to CCK-negative cells. In the case of LV-CCK-Cre, injections 
were performed on RosaLacZ mice and the resulting expression of 
LacZ, as detected by β-gal staining with X-gal, was co-localized with 
CCK mRNA by means of in situ hybridization. Both β-gal staining 
and GFP expression patterns closely paralleled CCK mRNA expres-
sion in the dentate, CA1, and fasciola cinereum regions of the hip-
pocampus (Figure 8). Taken together, these observations suggest that 
minimal CCK promoters are capable of producing highly selective 
expression in the appropriate sub-population of cells. Furthermore, 
when used as promoters in lentivirus constructs, similar approaches 
will allow for in vivo cell-type speciﬁ  c expression of transgenes that 
are biologically relevant in the study of complex behaviors.
OTHER APPROACHES USING VIRAL VECTORS FOR GENE 
MANIPULATION
Many other potential uses of viral vector approaches to gene 
manipulation have not been discussed due to space constraints. 
It is important for the reader to be aware of the multitude of new 
approaches including gene silencing. In neuroscience, antisense 
oligonucleotide approaches were used with increasing frequency 
for about a decade (Van Oekelen et al., 2003), but there remained 
signiﬁ  cant concern that the mechanism of action and the speciﬁ  city 
of gene knockdown were unknown. In recent years, it has become 
increasingly appreciated that these antisense approaches likely were 
successful because of the previously unknown mechanisms of cel-
lular heteronuclear RNA silencing mechanisms, which utilize the 
DICER complex to prevent translation or lead to targeted mRNA 
degradation. This ﬁ  eld has grown exponentially in recent years, 
and is far beyond the scope of this brief review. Sufﬁ  ce it to say 
A
350
Dexamethasone Suppression Test Baseline Acoustic Startle
2.0
1.5
1.0
0.5
0.0
3
2
1
0
95 105 115
Decibels
Forced Swim Test
Float Time
A
U
*
*
*
*
GFP
CRF
GFP
CRF
GFP
M
i
n
u
t
e
s
M
i
n
u
t
e
s
CRF GFP CRF
300
250
200
150
100
50
0
1.75
1.50
1.25
1.00
0.75
0.50
0.25
0.00
1100 1700
Time
Escape Effort Time
*
DEX INJ
C
o
r
t
i
c
o
s
t
e
r
o
n
e
 
(
n
g
/
m
l
)
1900
B
C D
FIGURE 7 | Effect of LV-CRF injection on HPA axis feedback, 
anxiety-and depression-related behaviors. (A) HPA axis feedback 
as assessed by the dexamethasone suppression test. Corticosterone 
levels before and following a dexamethasone injection (shown by arrow) 
for LV-GFP control (closed symbol) and LV-CRF rats (open symbol). 
(B–D) LV-GFP-injected control (closed bars) and LV-CRF-injected rats 
(open bars). (B) Baseline acoustic startle response, (C) amount of time 
animals spent actively trying to escape and (D) and time spent ﬂ  oating in 
the forced swim test. Mean ± SEM. *P < 0.05. Panels adapted from 
Keen-Rhinehart et al. (2009).Frontiers in Molecular Neuroscience  www.frontiersin.org  November 2009  | Volume 2  |  Article 22  |  11
Heldt and Ressler  Lentivirus-Cre/loxP for manipulation of behavior
that small heteronuclear RNAs have been successfully encoded in 
lentiviral and AAV vectors in neuroscience applications to silence 
genes (Janas et al., 2006; Harper and Gonzalez-Alegre, 2008), and 
this approach will undoubtedly continue to grow rapidly.
Another area of unprecedented growth and excitement concerns 
light-activated ion channels which have been utilized with tremen-
dous success by Deisseroth and colleagues (Boyden et al., 2005; 
Arenkiel et al., 2007). Several excellent reviews have been written 
about this new approach and the burgeoning ﬁ  eld of ‘optogenetics’ 
that has resulted (Airan et al., 2007; Gradinaru et al., 2007). In brief, 
these approaches have shown that speciﬁ  c ion channels from green 
algae which respond to light can be expressed in the brain via both 
transgenic and viral vector approaches. Different channels have 
been identiﬁ  ed and engineered which respond to different frequen-
cies of light as well as produce different channel characteristics (e.g., 
excitation vs. inhibition). By combining localized infection with 
viral vectors with implanted ﬁ  ber-optics, Deisseroth and colleagues 
have elegantly shown that they can   produce   cell-type   speciﬁ  c 
PoDG
PoDG
PoDG
A B
DE F
G H I
C
FIGURE 8 | In vivo validation of cell-type speciﬁ  c LV-CCK lentivirus. CCK 
mRNA expression. CCK mRNA was examined using in situ hybridization, 
demonstrating high levels of expression within the hippocampal formation [low 
power (A), high power (B,C)]. (B) Intense CCK mRNA expression is normally 
present within the CA3 subﬁ  eld and within the interneuron-rich region (PoDG) 
separating the granule cell layers of the dentate gyrus, and (C) in the fasciola 
cinereum medial to CA1. (D) Low power image showing LacZ expression parallels 
CCK mRNA expression in RosaLacZ Cre-reporter mice injected with LV-CCK-Cre. 
LacZ expression (blue precipitate) and CCK mRNA expression (silver grains) were 
assessed in the same sections. (E) High-power images showing a high degree of 
overlap in mRNA expression was observed in the polymorph layer of the dentate 
(high power). High and low panels depict images of low and high CCK mRNA 
expression in the polymorph layer of the dentate, with correspondingly low and 
high numbers of LacZ-positive cells. (F) Similar co-expression was seen in the 
fasciola cinereum. (G–I) Virus encoding CCK-GFP injected into the dentate gyrus 
of adult mice. (G) Fluorescence was assessed on sectioned, ﬁ  xed tissue. 
(H) Hoechst-stained photomicrographs of the same section shown in (G). 
(I) Overlays of (G) and (H). Panels adapted from Chhatwal et al. (2007).Frontiers in Molecular Neuroscience  www.frontiersin.org  November 2009  | Volume 2  |  Article 22  |  12
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  activation within deﬁ  ned neural   pathways. These approaches are 
  expanding quickly, and they have the promise of revolutionizing 
systems neurobiology.
In summary, viral vectors (particularly lentivirus) and Cre/
loxP mediated deletion provide powerful methods to induc-
ibly manipulate gene expression in the brain. When combined, 
they provide for the ability to over-express and delete genes of 
 interest in a temporal, spatial, and cell-type speciﬁ  c fashion. Such 
inducible genetic approaches will allow for eventual understand-
ing of the differential roles of genes in speciﬁ  c neural pathways 
which underlie the enormous complexity of brain function 
and behavior.
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